Marico Q1 FY26 revenue rises 23.3%; profit up 8.2% as India business accelerates
Marico reported Q1 FY26 consolidated revenue of Rs 3,259 crore and net profit of Rs 513 crore. India revenue grew 27.2% year-on-year to Rs 2,495 crore, while international revenue rose 12.9%. The company also raised its fully diluted stake in Plix maker Satiya Nutraceuticals to 60%.
What happened
Marico posted Q1 FY26 profit growth of 8.2% and revenue growth of 23.3%, led by 27.2% India revenue growth. It expects resilient FY26 momentum despite commodity
Key facts
- Q1 FY26 consolidated net profit rose 8.2% YoY to Rs 513 crore from Rs 474 crore
- Revenue from operations rose 23.31% to Rs 3,259 crore from Rs 2,643 crore
- Total income was Rs 3,315 crore, including Rs 56 crore other income
- Total expenses rose to Rs 2,659 crore from Rs 2,075 crore
- India revenue rose 27.17% to Rs 2,495 crore from Rs 1,962 crore
- International revenue rose 12.91% to Rs 764 crore from Rs 681 crore
- India segment PBT was Rs 469 crore
- International segment PBT was Rs 213 crore
- Marico increased its stake in Satiya Nutraceuticals to 60% on a fully diluted basis
Why this matters
Raising its stake in Plix maker Satiya Nutraceuticals to 60% strengthens Marico’s exposure to the fast-growing nutrition and wellness category.
What to watch
- Sequential gross-margin and EBITDA-margin trend versus the gap between revenue and net-profit growth.
- Copra, edible oil, crude-linked packaging and freight cost movements.
- Volume growth versus price-led growth in the India business.
- Plix revenue growth, distribution expansion, cash burn/profitability trajectory and impairment risk.
- Rural demand, urban discretionary spending and competitive promotional intensity.
- Management commentary on FY26 revenue-growth guidance, ad-spend intensity and price hikes.
- Increase brand investment and retail execution behind core India franchises to defend growth momentum.
- Scale Plix through Marico's distribution network, digital marketing capabilities and product pipeline while working toward margin-accretive integration.
- Take selective pricing, pack-size and procurement actions if commodity costs remain elevated.
- Prioritise premium and value-added launches in foods, health, hair care and personal care to improve mix.